Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
BörsenkürzelSNWV
Name des UnternehmensSANUWAVE Health Inc
IPO-datumNov 07, 2008
CEOFrank (Morgan C)
Anzahl der mitarbeiter46
WertpapierartOrdinary Share
GeschäftsjahresendeNov 07
Addresse9600 W. 6Th Sstreet
StadtEDEN PRAIRIE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55344
Telefon19526561029
Websitehttps://sanuwave.com/
BörsenkürzelSNWV
IPO-datumNov 07, 2008
CEOFrank (Morgan C)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten